0001593968-19-001743.txt : 20190816 0001593968-19-001743.hdr.sgml : 20190816 20190816160650 ACCESSION NUMBER: 0001593968-19-001743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190814 FILED AS OF DATE: 20190816 DATE AS OF CHANGE: 20190816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MICHEL GERARD J CENTRAL INDEX KEY: 0001235644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 191033512 MAIL ADDRESS: STREET 1: 420 CHIPETA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2019-08-14 0000887359 Vericel Corp VCEL 0001235644 MICHEL GERARD J C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 false true false false CFO and VP, Corp. Development Common Stock 2019-08-14 4 M false 17000 3.02 A 140182 D Common Stock 2019-08-14 4 S false 17000 16.6204 D 123182 D Stock Option (right to buy) 3.02 2019-08-14 4 M false 17000 0 D 2025-01-05 Common Stock 17000 69769 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. /s/ Dominick C. Colangelo, Attorney-in-Fact for Gerard Michel 2019-08-16